Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Martin

Showing results (31-40 of 130) with videos related to

Pageof 13
Sort By:
Health Services Research|June 1, 1991
The financial effect of physician practice style on hospital resource useJ Feinglass, G J Martin, A Sen
Archives of Biochemistry|March 19, 2010
d (--) Methylfolic acid displacing agent for folic acidG J MARTIN, L TOLMAN, J MOSS
Archives of Biochemistry|March 19, 2010
The hypotensive action of 7-methylpteroylglutamic acidG J MARTIN, L TOLMAN, R BRENDEL
The Journal of Biological Chemistry|March 19, 2010
Folic acid activity of N-(4-(4-quinazoline)-benzoyl)glutamic acidG J MARTIN, J MOSS, S AVAKIAN
Postgraduate Medicine|June 27, 2001
Manifestations of tick-borne illness. Incidence and variety are increasing worldwideC Goodman, A A Lazarus, G J Martin
The Western Journal of Medicine|October 1, 1993
Prognosis after graft replacement operation for abdominal aortic aneurysmJ Feinglass, W H Pearce, G J Martin
Journal of Wound Care|August 5, 2003
How sedative medication in older people affects patient risk factors for developing pressure ulcersL A Lindquist, J Feinglass, G J Martin
American Heart Journal|September 1, 1981
Neurologic symptoms from calcific microemboli in aortic stenosisG J Martin, J M Moran, M Lesch
Annals of Internal Medicine|December 1, 1981
Predisposing factors for pulmonary embolismG J Martin, S Shoichet, H G Martin
Spine|November 24, 1999
Recombinant human bone morphogenetic protein-2 overcomes the inhibitory effect of ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), on posterolateral lumbar intertransverse process spine fusionG J Martin, S D Boden, L Titus
Pageof 13

Showing results (31-40 of 130) with videos related to

Sort By:
Pageof 13
Health Services Research|June 1, 1991
The financial effect of physician practice style on hospital resource useJ Feinglass, G J Martin, A Sen
Archives of Biochemistry|March 19, 2010
d (--) Methylfolic acid displacing agent for folic acidG J MARTIN, L TOLMAN, J MOSS
Archives of Biochemistry|March 19, 2010
The hypotensive action of 7-methylpteroylglutamic acidG J MARTIN, L TOLMAN, R BRENDEL
The Journal of Biological Chemistry|March 19, 2010
Folic acid activity of N-(4-(4-quinazoline)-benzoyl)glutamic acidG J MARTIN, J MOSS, S AVAKIAN
Postgraduate Medicine|June 27, 2001
Manifestations of tick-borne illness. Incidence and variety are increasing worldwideC Goodman, A A Lazarus, G J Martin
The Western Journal of Medicine|October 1, 1993
Prognosis after graft replacement operation for abdominal aortic aneurysmJ Feinglass, W H Pearce, G J Martin
Journal of Wound Care|August 5, 2003
How sedative medication in older people affects patient risk factors for developing pressure ulcersL A Lindquist, J Feinglass, G J Martin
American Heart Journal|September 1, 1981
Neurologic symptoms from calcific microemboli in aortic stenosisG J Martin, J M Moran, M Lesch
Annals of Internal Medicine|December 1, 1981
Predisposing factors for pulmonary embolismG J Martin, S Shoichet, H G Martin
Spine|November 24, 1999
Recombinant human bone morphogenetic protein-2 overcomes the inhibitory effect of ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), on posterolateral lumbar intertransverse process spine fusionG J Martin, S D Boden, L Titus
Pageof 13